With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- The restrictions in Archena reactivate the internal battle in the regional PP Jul 15, 2021
- After the end of the lockdown: The first theaters will be playing again from… Dec 20, 2020
- Men and women: Gemma Galgani rejected by everyone? Sep 6, 2021
- Australia: A chemistry lesson turns tragic in a school, 11 students burned Nov 21, 2022
- José Eduardo Derbez was a victim of identity theft and these were the consequences Sep 19, 2020
- Alessandro D’amico donated a kidney to his sister – Curler Jul 6, 2021
- Renzi wants to lighten the Zan Bill: “Better a compromise with the right than nothing” Jul 5, 2021